FGF2 and cancer: Moreover, several growth factors, including insulin-like growth factor 1 (IGF-1), basic fibroblast growth factor 2 (FGF2), and epidermal growth factor (EGF), can greatly activate the PI3K-AKT pathway, thereby facilitating malignant behaviors of cancers 12-16.